Hong Kong Exchanges & Clearing (00388.HK) 2021 earnings up 9% slightly miss expectations

22 Apr 2022

Amid continuing market volatility and a slowdown in the Q4
HKEX reported 4Q2021 revenue of HK$4.73bn, -7.2% YoY and -10.9% QoQ. Shareholders’
net profit was HK$2.67bn, down 8.6% YoY, 17.8% QoQ, slightly below the consensus
estimates. Although 2021 started exceptionally well, 1Q2021 with record quarterly Headline
ADT of $224.4bn, 2Q2021 & 3Q2021 ADT both higher than the same period in 2020.
However, amid continuing market volatility in 2021 and a slowdown in 4Q2021. The ADT 4Q
has dropped to 126.4bn, down 24% YoY. In addition, Derivatives ADV decreased by 17% and
ADT of Northbound Trading of Stock Connect decreased by 20%, resulting in trading and
clearing fees decline in 4Q. Operating expenses decreased by 7.8% YoY, due to lower staff
expenses. This led to EBITDA margins broadly flat as 74%. The IPO pipeline remained very
robust, with the demand of US-listed Chinese companies homecoming listings in Hong Kong,
as well as the introduction of a listing regime for SPACs and the enhanced listing regime for
overseas issuers. However, numerous challenges posed by uncertainty surrounding the
continued inflationary pressure, the tightening of the Fed’s monetary policy, the entry of
interest rate hike cycle, ongoing geopolitical risks and the pandemic recovery.
2021 Annual Results
FY2021, revenue and other income of HK$20.95bn, up 9% against the previous record set in
2020. Profit attributable to shareholders up 9%, to a record high of HK$12.5bn. Core
business revenue of HK$20.1bn, up 10% compared with 2020, benefit from the headline
ADT set new record in 2021, reaching HK$166.7bn, up 29% YoY. Record Stock Connect
revenue and other income of HK$2.724bn, up 41% YoY. Stock Connect Northbound and
Southbound reached record annual turnover of RMB27.6 trillion and $9.3 trillion, up 31%
and 70% YoY, respectively, and record ADT of RMB120.1bn and $41.7bn, up 32 per cent and
71% YoY, respectively. Operating expenses increased by 2% compared with 2020, mainly
due to higher IT and computer maintenance expenses and higher product marketing
expenses and cash incentives for new products. EBITDA margin was 78%, 1 per cent higher
than 2020.
2021 review, with a total of 98 company listings raising HK$331.4bn, down from the strong
2020 (154 company listings raising HK$400.2bn) and 5% higher than 2019 (HK$314.2bn).
During the year, 59 new economy companies, including 31 Weighted Voting Rights (WVR),
healthcare and biotech firms (including Chapter 18A listings only) and/or secondary-listed
companies, accounting for 88% of IPO funds raised in Hong Kong during the period. Total
market turnover in 2021 reached HK$41.2 trillion, up 28% compared with 2020. Total
turnover of securitized derivatives (DWs, CBBCs and Inline Warrants) reached HK$4,956.8bn,
up 8% compared with 2020. As world metal trading remained under pressure, the
chargeable average daily volume of metals contracts traded on the LME decreased by 4%
from 2020

About the author

Eric Li
Analyst
Research

李浩然先生(Eric Li) 高級分析師 現任現為輝立証券持牌高級分析師,曾任職股票基金、家族辦公室及證券公司等,擁有多年的證券研究部門從業及投資經驗,並先後於香港最暢銷的財經媒體撰寫投資專欄。畢業於香港理工大學電子計算系。 Eric is currently a licensed research analyst at Phillip Securities. Prior to joining Phillip Securities, he has years of equity research and investment experiences in asset management company, family office and securities company. Meanwhile, he has written investment columns in Hong Kong`s best-selling financial media for years. He holds Bachelor of Arts in Computing from The Hong Kong Polytechnic University.

Latest Reports

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com